Cancer Research AACR Conference on Molecular Diagnostics - 2008
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 54, 3413-3421, July 1, 1994]
© 1994 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Danielpour, D.
Right arrow Articles by Sporn, M. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Danielpour, D.
Right arrow Articles by Sporn, M. B.

Development and Characterization of Nontumorigenic and Tumorigenic Epithelial Cell Lines from Rat Dorsal-Lateral Prostate

David Danielpour1, Kenji Kadomatsu, Mario A. Anzano, Joseph M. Smith and Michael B. Sporn

Laboratory of Chemoprevention, National Cancer Institute, Bethesda, Maryland 20892

We have established two new epithelial cell lines (NRP-152, NRP-154), with markedly different properties, from the dorsal-lateral prostate of Lobund/Wistar rats treated with N-methyl-N-nitrosourea and testosterone propionate. NRP-152 cells do not form tumors in athymic mice and retain many of the properties of normal prostatic epithelial cells. They produce prostatic acid phosphatase, have functional androgen receptors, and require the combination of several growth factors in addition to serum for optimal growth. Their growth is stimulated by epidermal growth factor, insulin, dexamethasone, cholera toxin, dihydrotestosterone, and testosterone, and their growth is inhibited by transforming growth factor ßs and retinoic acid. These cells also respond to 1,25-dihydroxy-vitamin D3 with an early growth stimulation followed by growth inhibition at later times. In contrast, tumorigenic NRP-154 cells lack detectable androgen receptor mRNA and have less stringent growth factor requirements for optimal growth. Growth of NRP-154 cells is stimulated by dexamethasone and insulin, inhibited by transforming growth factor ß1, but not significantly altered by epidermal growth factor, cholera toxin, dihydrotestosterone, retinoic acid, or 1{alpha},25-dihydroxyvitamin D3. Our data suggest that the NRP-152 and NRP-154 cell lines are suitable systems for analysis of normal prostate growth and prostatic carcinogenesis.

1 To whom requests for reprints should be addressed.

Received 9/30/93. Accepted 4/27/94.




This article has been cited by other articles:


Home page
Mol Cancer ResHome page
K. L. Nastiuk, K. Yoo, K. Lo, K. Su, P. Yeung, J. Kutaka, D. Danielpour, and J. J. Krolewski
FLICE-Like Inhibitory Protein Blocks Transforming Growth Factor {beta}1-Induced Caspase Activation and Apoptosis in Prostate Epithelial Cells
Mol. Cancer Res., February 1, 2008; 6(2): 231 - 242.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
W. Kleeberger, G. S. Bova, M. E. Nielsen, M. Herawi, A.-Y. Chuang, J. I. Epstein, and D. M. Berman
Roles for the Stem Cell Associated Intermediate Filament Nestin in Prostate Cancer Migration and Metastasis
Cancer Res., October 1, 2007; 67(19): 9199 - 9206.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
C.-T. Wu, S. Altuwaijri, W. A. Ricke, S.-P. Huang, S. Yeh, C. Zhang, Y. Niu, M.-Y. Tsai, and C. Chang
Increased prostate cell proliferation and loss of cell differentiation in mice lacking prostate epithelial androgen receptor
PNAS, July 31, 2007; 104(31): 12679 - 12684.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
L. A. Gomez, A. de las Pozas, T. Reiner, K. Burnstein, and C. Perez-Stable
Increased expression of cyclin B1 sensitizes prostate cancer cells to apoptosis induced by chemotherapy
Mol. Cancer Ther., May 1, 2007; 6(5): 1534 - 1543.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
L. Huang, Y. Pu, D. Hepps, D. Danielpour, and G. S. Prins
Posterior Hox Gene Expression and Differential Androgen Regulation in the Developing and Adult Rat Prostate Lobes
Endocrinology, March 1, 2007; 148(3): 1235 - 1245.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Cai, P. Lin, K.-H. Cheung, N. Li, C. Levchook, Z. Pan, C. Ferrante, G. L. Boulianne, J. K. Foskett, D. Danielpour, et al.
The Presenilin-2 Loop Peptide Perturbs Intracellular Ca2+ Homeostasis and Accelerates Apoptosis
J. Biol. Chem., June 16, 2006; 281(24): 16649 - 16655.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
L. A. Gomez, A. de las Pozas, and C. Perez-Stable
Sequential combination of flavopiridol and docetaxel reduces the levels of X-linked inhibitor of apoptosis and AKT proteins and stimulates apoptosis in human LNCaP prostate cancer cells
Mol. Cancer Ther., May 1, 2006; 5(5): 1216 - 1226.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
M. Pollard and M. A. Suckow
Hormone-Refractory Prostate Cancer in the Lobund-Wistar Rat
Experimental Biology and Medicine, September 1, 2005; 230(8): 520 - 526.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
T. Ikezoe, S. Gery, D. Yin, J. O'Kelly, L. Binderup, N. Lemp, H. Taguchi, and H. P. Koeffler
CCAAT/Enhancer-Binding Protein {delta}: A Molecular Target of 1,25-Dihydroxyvitamin D3 in Androgen-Responsive Prostate Cancer LNCaP Cells
Cancer Res., June 1, 2005; 65(11): 4762 - 4768.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Wang, K. Song, T. L. Sponseller, and D. Danielpour
Novel Function of Androgen Receptor-associated Protein 55/Hic-5 as a Negative Regulator of Smad3 Signaling
J. Biol. Chem., February 18, 2005; 280(7): 5154 - 5162.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
K. V. Desai, A. M. Michalowska, P. Kondaiah, J. M. Ward, J. H. Shih, and J. E. Green
Gene Expression Profiling Identifies a Unique Androgen-Mediated Inflammatory/Immune Signature and a PTEN (Phosphatase and Tensin Homolog Deleted on Chromosome 10)-Mediated Apoptotic Response Specific to the Rat Ventral Prostate
Mol. Endocrinol., December 1, 2004; 18(12): 2895 - 2907.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
B. E. Barton, T. F. Murphy, P. Shu, H. F. Huang, M. Meyenhofen, and A. Barton
Novel single-stranded oligonucleotides that inhibit signal transducer and activator of transcription 3 induce apoptosis in vitro and in vivo in prostate cancer cell lines
Mol. Cancer Ther., October 1, 2004; 3(10): 1183 - 1191.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Song, S. C. Cornelius, M. Reiss, and D. Danielpour
Insulin-like Growth Factor-I Inhibits Transcriptional Responses of Transforming Growth Factor-{beta} by Phosphatidylinositol 3-Kinase/Akt-dependent Suppression of the Activation of Smad3 but Not Smad2
J. Biol. Chem., October 3, 2003; 278(40): 38342 - 38351.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
K. Song, S. C. Cornelius, and D. Danielpour
Development and Characterization of DP-153, a Nontumorigenic Prostatic Cell Line That Undergoes Malignant Transformation by Expression of Dominant-negative Transforming Growth Factor {beta} Receptor Type II
Cancer Res., August 1, 2003; 63(15): 4358 - 4367.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
T. Kumagai, J. O'Kelly, J. W. Said, and H. P. Koeffler
Vitamin D2 Analog 19-nor-1,25-Dihydroxyvitamin D2: Antitumor Activity Against Leukemia, Myeloma, and Colon Cancer Cells
J Natl Cancer Inst, June 18, 2003; 95(12): 896 - 905.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
G. S. Prins, W. Y. Chang, Y. Wang, and R. B. van Breemen
Retinoic Acid Receptors and Retinoids Are Up-Regulated in the Developing and Adult Rat Prostate by Neonatal Estrogen Exposure
Endocrinology, September 1, 2002; 143(9): 3628 - 3640.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. E. Chipuk, L. V. Stewart, A. Ranieri, K. Song, and D. Danielpour
Identification and Characterization of A Novel Rat Ov-Serpin Family Member, Trespin
J. Biol. Chem., July 12, 2002; 277(29): 26412 - 26421.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
C. M. Perez-Stable, G. G. Schwartz, A. Farinas, M. Finegold, L. Binderup, G. A. Howard, and B. A. Roos
The G{gamma}/T-15 Transgenic Mouse Model of Androgen-independent Prostate Cancer: Target Cells of Carcinogenesis and the Effect of the Vitamin D Analogue EB 1089
Cancer Epidemiol. Biomarkers Prev., June 1, 2002; 11(6): 555 - 563.
[Abstract] [Full Text] [PDF]


Home page
Cell Growth Differ.Home page
S. Larisch-Bloch, D. Danielpour, N. S. Roche, R. Lotan, A. Y. Hsing, H. Kerner, T. Hajouj, R. J. Lechleider, and A. B. Roberts
Selective Loss of the Transforming Growth Factor-{beta} Apoptotic Signaling Pathway in Mutant NRP-154 Rat Prostatic Epithelial Cells
Cell Growth Differ., January 1, 2000; 11(1): 1 - 10.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
T. J. Ahonen, P. L. Härkönen, J. Laine, H. Rui, P. M. Martikainen, and M. T. Nevalainen
Prolactin Is a Survival Factor for Androgen-Deprived Rat Dorsal and Lateral Prostate Epithelium in Organ Culture
Endocrinology, November 1, 1999; 140(11): 5412 - 5421.
[Abstract] [Full Text]


Home page
Cancer Res.Home page
B. Tang, K. de Castro, H. E. Barnes, W. T. Parks, L. Stewart, E. P. Bottinger, D. Danielpour, and L. M. Wakefield
Loss of Responsiveness to Transforming Growth Factor {beta} Induces Malignant Transformation of Nontumorigenic Rat Prostate Epithelial Cells
Cancer Res., October 1, 1999; 59(19): 4834 - 4842.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J.-i. Hisatake, T. Kubota, Y. Hisatake, M. Uskokovic, S. Tomoyasu, and H. P. Koeffler
5,6-trans-16-ene-Vitamin D3: A New Class of Potent Inhibitors of Proliferation of Prostate, Breast, and Myeloid Leukemic Cells
Cancer Res., August 1, 1999; 59(16): 4023 - 4029.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
N. Suh, Y. Wang, T. Honda, G. W. Gribble, E. Dmitrovsky, W. F. Hickey, R. A. Maue, A. E. Place, D. M. Porter, M. J. Spinella, et al.
A Novel Synthetic Oleanane Triterpenoid, 2-Cyano-3,12-dioxoolean-1,9-dien-28-oic Acid, with Potent Differentiating, Antiproliferative, and Anti-Inflammatory Activity
Cancer Res., January 1, 1999; 59(2): 336 - 341.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
D Danielpour
Transdifferentiation of NRP-152 rat prostatic basal epithelial cells toward a luminal phenotype: regulation by glucocorticoid, insulin-like growth factor-I and transforming growth factor-beta
J. Cell Sci., January 1, 1999; 112(2): 169 - 179.
[Abstract] [PDF]


Home page
Biol. Reprod.Home page
P. P. Banerjee, S. Banerjee, J. M. Lai, J. D. Strandberg, B. R. Zirkin, and T. R. Brown
Age-Dependent and Lobe-Specific Spontaneous Hyperplasia in the Brown Norway Rat Prostate
Biol Reprod, November 1, 1998; 59(5): 1163 - 1170.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
J. Su, X. Chai, B. Kahn, and J. L. Napoli
cDNA Cloning, Tissue Distribution, and Substrate Characteristics of a cis-Retinol/3alpha -Hydroxysterol Short-chain Dehydrogenase Isozyme
J. Biol. Chem., July 10, 1998; 273(28): 17910 - 17916.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
P. J. Russell, S. Bennett, and P. Stricker
Growth factor involvement in progression of prostate cancer
Clin. Chem., April 1, 1998; 44(4): 705 - 723.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
X. Chai, Y. Zhai, and J. L. Napoli
cDNA Cloning and Characterization of a cis-Retinol/3alpha -Hydroxysterol Short-chain Dehydrogenase
J. Biol. Chem., December 26, 1997; 272(52): 33125 - 33131.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. E. Chipuk, M. Bhat, A. Y. Hsing, J. Ma, and D. Danielpour
Bcl-xL Blocks Transforming Growth Factor-beta 1-induced Apoptosis by Inhibiting Cytochrome c Release and Not by Directly Antagonizing Apaf-1-dependent Caspase Activation in Prostate Epithelial Cells
J. Biol. Chem., July 6, 2001; 276(28): 26614 - 26621.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. E. Chipuk, S. C. Cornelius, N. J. Pultz, J. S. Jorgensen, M. J. Bonham, S.-J. Kim, and D. Danielpour
The Androgen Receptor Represses Transforming Growth Factor-beta Signaling through Interaction with Smad3
J. Biol. Chem., January 4, 2002; 277(2): 1240 - 1248.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1994 by the American Association for Cancer Research.